Impact BioMedical (IBO)

• Market cap: $62.8M
• 1 day: -6%
• 5 days: 33.64%
• 1 month: 35.53%
• 3 months: 16.98%
• 6 months: -10.05%
• Year to date: 12.4%
• 1 year: -82.34%
• 5 years: -78.25%
• 10 years: -78.25%
• Sector: Healthcare
• Industry: Drug Manufacturers - General

About: Impact BioMedical Inc focuses on the advancement of drug discovery and prevention, inhibition, and treatment of neurological, oncological, and immune-related diseases. The company is also developing open-air defense initiatives, which curb transmission of air-borne infectious diseases, such as tuberculosis and influenza. Its technologies inlcude Linebacker, Laetose, 3F, and Equivir.

Employees: 8